Answer
Riluzole is contraindicated in patients with hepatic disease or baseline transaminases greater than three times the upper limit of normal.
Sources for this answer
- Riluzole 50 mg film-coated tabletsRanbaxy (UK) Limited a Sun Pharmaceutical Company · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked